• MORE MARKET STATS

E Kumar Sharma

Articles By E Kumar Sharma

87 Articles

Covaxin interim efficacy very good, awaiting more data and full results: Dr Gagandeep Kang

“Interim efficacy results are a planned analysis and are showing very good results for Covaxin. This is excellent news,” says Dr Gagandeep Kang, a highly regarded medical scientist and professor at the Christian Medical C

covaxin news

COVID-19: New test to measure vaccine-induced immune response

Late last year, Basel-headquartered healthcare major Roche came up with a test to measure the level of antibodies in people who have been exposed to the SARS-CoV-2 virus.

coronavirus, coronavirus update, coronavirus in India, coronavirus test, coronavirus antibodies test, covid update, covid test update

Naidu’s detention unfair, says TDP MP Galla; Left with no other option in times of COVID: Chittoor SP

Naidu was on his way to meet the district collector there and make a representation to him on the unfair practices being adopted by the officials of the state machinery and the treatment being meted out to the party candidate

N Chandrababu Naidu

Sharp recovery on, expect GDP & GVA numbers to converge soon: Sanjeev Sanyal

The real GDP at constant (2011-12) prices in the year 2020-21 is estimated to attain a level of ₹134.09 lakh crore, as against the first revised estimate of GDP for the year 2019-20 of ₹145.69 lakh crore.

GDP, GDP latest, GDP news, latest GDP, Sanjeev Sanyal, National Statistical Office, Indian Economy

Clear recovery underway but much better GVA & Q4 growth crucial for any sharp upturn: Rangarajan

Agreeing that there undoubtedly is an economic recovery underway, Dr C Rangarajan, economist and the former governor of the RBI prefers to still stay cautious.

India, Indian economy, GDP, GDP numbers, latest GDP numbers v-shaped recovery, Dr C Rangarajan, RBI, reserve bank of India

India’s tryst with deep tech & the art of spawning disruptors

If companies from India are to transition from a volume play to a value play and look beyond low cost, greater efficiency cycle and seek an orbital shift in capital and wealth creation then investing in ownership of intellect

Promote traditional medicine with data, clinical trial studies, and research papers: IMA chief

IMA clarifies it is not against Ayurveda or any other form of traditional Indian medicine but feels the only way to promote it is by backing each product or solution with scientific rigour.

Coronil, Ayush Ministry certification, WHO scheme, baba ramdev, Patanjali Ayurved, covid19 medicine Coronil, Health Minister Harsh Vardhan, Transport Minister Nitin Gadkari, Coronil gets CoPP, Coronil export, Ayush Ministry, Immuno-booste

COVID-19: Expert panel not for shift in Covishield vaccine dose spacing

In addition, apparently, there was also a view emerging that in the current context there are risks in extending the gap between vaccine doses primarily because people are moving around with sub-optimal immunity and increasin

covishield

Growth stimulating investments with clear road map on fiscal consolidation crucial now: Dr Rangarajan

The difference between the total revenue receipts (both tax and non-tax revenue) and the interest payments gives a good indicator of how much of the revenue receipt is available to the government

c rangarajan

CEA to bankers: If you want books in order then let your ‘karma’ be driven by your ‘dharma’

CEA Krishnamurthy V Subramanian was delivering the 11th R K Talwar memorial lecture organised by the Indian Institute of Banking and Finance.

CEA Krishnamurthy V Subramanian

GVK power plant on alert following Uttarakhand glacier burst

The group can hardly afford to suffer adverse developments having tried to recover this power plant from a natural disaster earlier.

glacier burst

COVID-19 vaccine: Case now to ramp up supplies at lower prices, says expert

The two vaccines approved by the Indian government for emergency use also do not have the challenge of storage at ultra-low temperatures and there is the assurance of adequate supplies.

COVID-19 vaccine: Case now to ramp up supplies at lower prices, says expert

COVID-19: Don’t let the guard down, caution experts

Other than masks and physical distancing, vaccines are the only hope and it is erroneous to assume that one can get back to a pre-pandemic routine because a large part of India has still not been exposed to the virus.

COVID-19: Don’t let the guard down, caution experts

Budget 2021: Rise in expenditure marginal but shift in its composition significant, says Dr Rangarajan

Union Budget 2021 India: Economist and the former governor of the Reserve Bank of India (RBI) Dr C Rangarajan who has been watching the economy closely as tries to cope with the economic scars following the pandemic, is happy

Budget 2021-22, Union Budget 2021

Health finally on upward trajectory, direction of fund flow is all that matters now, says Gagandeep Kang

Union Budget 2021 India: One of the major highlights of the budget has been health care taking the centre-stage. Or as India’s highly regarded medical scientist Gagandeep Kang, professor at the Christian Medical College, Ve

Budget 2021-22, Union Budget 2021

Economic Survey hails Ayushman Bharat even as govt replaces founding CEO Indu Bhushan

At a press conference on the Eco Survey 2020-21, CEA Krishnamurthy Subramanian explained how improvement in insurance coverage with Ayushman Bharat had led to better health outcomes be it around dealing with infant and child

Indu Bhushan

US is back but why WHO needs to be healthcare’s IMF

The ask is a humble sum and the pitch is to invest in health for all. Yet, the global guardian of public health, as the World Health Organisation (WHO) describes itself, is left scurrying for funds.

WHO, covid 19

Focus needs to stay on tracking virus behaviour and on ramping up vaccine supplies: WHO’s Dr Swaminathan

“Globally, there is a vaccine supply shortage resulting in a huge mismatch between supply and demand but this will improve during the course of the year (2021)," says Dr Soumya Swaminathan, chief scientist at the World Heal

Soumya Swaminathan on India Covid vaccination

COVID-19: Enemy is down but not out, cautions CCMB director Rakesh Mishra

Despite experts pointing out repeatedly that masks and social distancing is the only hope, many are willing to let their guard down against coronavirus pandemic.

coronavirus, coronavirus in India, India coronavirus, coronavirus second wave, covid second wave, new virus, virus mutation, virus strain, India coronavirus latest, corona masks, social distancing, covid protocols

COVID-19 vaccine: Serum gets order for 11 million out of 600 million doses needed

This taken at the Rs 200 per dose price quoted by Serum Insitute means an order worth Rs 220 crore, which apparently is an amount to be spent under the PM Cares Fund.

These and several other questions continue to emerge as long as there is no clarity from the government on its plans on procurement and distribution.

Serum Institute yet to receive orders for vaccine supply

SII has already offered the vaccine to the government at Rs 200 per dose and though, it is learnt, this is also not the final price as yet.

Serum Institute yet to receive orders for vaccine supply

Less than 10 days to vaccine rollout, crucial questions remain unanswered

The silver lining in this whole exercise is perhaps the fact that the government has already concluded dry runs across regions with hopefully some useful insights. Equally important is the fact that the government has a digit

covid vaccine

COVID vaccine: We have not got a pre-mature approval, says Bharat Biotech’s Dr Krishna Ella

Calling Bharat Biotech as a company that understands vaccines having produced 16 vaccines and spread across 123 countries, Dr Krishna Ella responded to a wide range of questions from the media.

COVID vaccine: We have not got a pre-mature approval, says Bharat Biotech’s Dr Krishna Ella

COVID vaccine: Why is Bharat Biotech in the spotlight?

The major question on the issue of the authorization is centered around the point that the phase III trials of the vaccine have not yet been completed.

Bharat Biotech ,COVAXIN vaccine

COVID Vaccine: Expert panel for conditional nod to Serum-Oxford; meet on with Bharat Biotech

The Serum Institute vaccine is one among the three vaccines awaiting Emergency Use Authorisation approval (the other two being Bharat Biotech and Pfizer).

oxford covid vaccine in india distribution

Budget 2021: Watch experts on future of PSU banks, policy gaps on urban poor, production enablers and more

India Budget 2021: These and more issues were discussed at an online meeting organised by FE Online. Other than Dr Subbarao, there were Rama Bijapurkar, and Professor M S Sriram also shared their views.

budget 2021, budget 2021 expectations, Economy budget expectations, budget 2021 policy, PSU Banks expectation from budget 2021-21, budget 2021 india, budget expectations 2021 india, budget expectations 2021 India, budget 2021 expectations for economy, D Subbarao, RBI, Rama Bijapurkar, M S Sriram

Deliverance 2021: Indian firms up cold storage & vial supplies as govt readies vaccine roll out

Most of the vaccines need 2 to 8 degrees centigrade temperatures, including many of the COVID vaccines other than the likes of Pfizer and Moderna which need storage at much lower temperatures.

Deliverance 2021: Indian firms up cold storage & vial supplies as govt readies Covid 19 vaccine roll out
Advertisement
Income Tax Calculator, Budget 2019, How to Calculate Income Tax

 

Stock Market

Advertisement
Advertisement